SPNT:NYSESiriusPoint Ltd. Analysis

SiriusPoint (SPNT) is trading at $23.25, comfortably above its 20‑day ($23.17) and 50‑day ($21.86) simple moving averages, indicating a short‑term bullish bias, while the 30‑day volatility of ~22% and a decreasing volume trend suggest a waning momentum. The Relative Strength Index sits at 57, well within the neutral zone, and the MACD histogram has turned negative, flagging a potential near‑term pullback despite the overall bullish trend direction. At a trailing P/E of 6.4 the stock is markedly cheaper than the industry average of 17.5, yet the discounted cash‑flow fair‑value estimate of $19.28 places the current price above intrinsic expectations, implying limited upside beyond the model’s 13% upside projection. Fundamentally, SPNT delivered 19% revenue growth, solid profit margins (15% net), and a strong ROE of 21%, but free cash flow remains heavily negative, raising concerns about cash generation.
Recent material news includes an AM Best upgrade to an “A Excellent” financial strength rating and the upcoming Q1 2026 earnings release, both of which could catalyze short‑term price movement. The combination of low beta (~0.4), a modest debt‑to‑equity profile, and no dividend payout suggests the stock leans toward a value‑oriented play with a blend of growth attributes, while the elevated fear‑greed index (Extreme Greed) and proximity to its 52‑week high warrant caution.